Citius Pharmaceuticals, Inc. Reimbursement from Limited Partnership Investment
Citius Pharmaceuticals, Inc. (CTXR) reported Reimbursement from Limited Partnership Investment of $292.57 thousand for the 3-month period ending 2016-03-31, per its 10-K filed 2016-12-23.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ReimbursementFromLimitedPartnershipInvestment · last filed 2016-12-23
- Citius Pharmaceuticals, Inc. reimbursement from limited partnership investment for the quarter ending 2016-03-31 was $292.57K.
| Period end | Reimbursement from Limited Partnership Investment 3 month |
|---|---|
| 2016-03-31 | $292.57K 10-K · filed 2016-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |